Literature DB >> 26162241

Status epilepticus results in persistent overproduction of reactive oxygen species, inhibition of which is neuroprotective.

S Williams1, N Hamil1, A Y Abramov1, M C Walker1, S Kovac2.   

Abstract

Epilepsy and seizure activity result in the generation of reactive oxygen species (ROS), which contribute to seizure-induced neuronal damage. Recent in vitro evidence indicates that NADPH oxidase contributes significantly to seizure-induced ROS. We further tested this in rat glio-neuronal cultures and in ex vivo chronic epileptic rat brain tissue using live cell-imaging techniques. Here, we show that ROS are upregulated in chronic epilepsy and that ROS production contributes to cell death, which is seen after status epilepticus (SE) and chronic seizures. Inhibition of ROS production by AEBSF, a NADPH oxidase inhibitor, markedly reduced seizure-induced cell death in the perforant path model of epilepsy. These findings demonstrate a critical role for ROS, generated by NADPH oxidase, contributing to seizure-induced cell death. These findings point to NADPH oxidase inhibition as a novel treatment strategy to prevent brain injury in SE and chronic epilepsy.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NADPH oxidase; cell death; reactive oxygen species; seizures; status epilepticus

Mesh:

Substances:

Year:  2015        PMID: 26162241     DOI: 10.1016/j.neuroscience.2015.07.005

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Effect of Resveratrol on Oxidative Stress and Mitochondrial Dysfunction in Immature Brain during Epileptogenesis.

Authors:  Jaroslava Folbergrová; Pavel Ješina; Hana Kubová; Jakub Otáhal
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

2.  Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation.

Authors:  Pallavi B McElroy; Li-Ping Liang; Brian J Day; Manisha Patel
Journal:  Exp Neurol       Date:  2017-08-16       Impact factor: 5.330

3.  A Metabolic Paradigm for Epilepsy.

Authors:  Manisha Patel
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

4.  Impaired Bioenergetics in Mutant Mitochondrial DNA Determines Cell Fate During Seizure-Like Activity.

Authors:  Stjepana Kovac; Elisavet Preza; Henry Houlden; Matthew C Walker; Andrey Y Abramov
Journal:  Mol Neurobiol       Date:  2018-04-27       Impact factor: 5.590

Review 5.  The metabolic basis of epilepsy.

Authors:  Jong M Rho; Detlev Boison
Journal:  Nat Rev Neurol       Date:  2022-03-31       Impact factor: 44.711

Review 6.  Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury.

Authors:  Clifford L Eastman; Raimondo D'Ambrosio; Thota Ganesh
Journal:  Neuropharmacology       Date:  2019-12-06       Impact factor: 5.250

7.  Heterologous expression of the antimyotoxic protein DM64 in Pichia pastoris.

Authors:  Saulo Martins Vieira; Surza Lucia Gonçalves da Rocha; Ana Gisele da Costa Neves-Ferreira; Rodrigo Volcan Almeida; Jonas Perales
Journal:  PLoS Negl Trop Dis       Date:  2017-07-31

Review 8.  Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.

Authors:  Stjepana Kovac; Albena T Dinkova Kostova; Alexander M Herrmann; Nico Melzer; Sven G Meuth; Ali Gorji
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

9.  Neuronal Nitric Oxide Synthase Contributes to PTZ Kindling-Induced Cognitive Impairment and Depressive-Like Behavior.

Authors:  Xinjian Zhu; Jingde Dong; Bing Han; Rongrong Huang; Aifeng Zhang; Zhengrong Xia; Huanhuan Chang; Jie Chao; Honghong Yao
Journal:  Front Behav Neurosci       Date:  2017-10-18       Impact factor: 3.558

10.  Thymoquinone Attenuates Brain Injury via an Anti-oxidative Pathway in a Status Epilepticus Rat Model.

Authors:  Yi-Ye Shao; Bing Li; Yong-Mei Huang; Qiong Luo; Yang-Mei Xie; Ying-Hui Chen
Journal:  Transl Neurosci       Date:  2017-03-25       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.